LexDanaLexDanabeta
Inventor

Charles Gluchowski

Inventor
Wayne, NJ, US

Overview

69→
Patents
1988–2007
Patent span
Chemistry
Primary field (CPC C)

Patents· 69 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes22%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
7,208,502'Methods of treating conditions associated with an Edg-3 receptor'20076,777,426'Imidazole and imidazoline derivatives and uses thereof'20046,734,182'Aryl sulfonamides and sulfamide derivatives and uses thereof'20046,727,257'5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines'20046,723,741'Benzimidazoles and benzothiazoles and uses thereof'20046,720,324'Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof'20046,706,716'Compounds specific for the human 1d adrenergic receptor and uses thereof'20046,620,815'Oxazolidinones and uses thereof'20036,608,086'Dihydropyridines and new uses thereof'20036,602,888'Use of 1C specific compounds to treat benign prostatic hyperplasia'20036,531,471'Morpholinone and morpholine derivatives and uses thereof'20036,498,177'Indole and benzothiazole derivatives'20026,495,583'Benzimidazole derivatives'20026,436,982'Benzimidazole derivatives'20026,403,626'Benzimidazole derivatives'20026,391,877'Aryl sulfonamides and sulfamide derivatives and uses thereof'20026,362,182'Morpholinone and morpholine derivatives and uses thereof'20026,316,637'Benzimidazole derivatives'20016,310,076'Dihydropyridines and new uses thereof'20016,303,643'Substituted indoles and uses thereof'20016,294,566'Imidazoline derivatives and uses thereof'20016,268,369'5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines'20016,248,747'5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines'20016,245,773'5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines'20016,228,861'Dihydropyrimidines and uses thereof'20016,218,390'Morpholinone and morpholine derivatives and uses thereof'20016,211,241'Aryl sulfonamides and sulfamide derivatives and uses thereof'20016,211,198'Dihydropyridines and new uses thereof'20016,172,066'Dihydropyrimidines and uses thereof'20016,159,990'Oxazolidinones as .alpha..sub.1A receptor antagonists'20006,159,998'Substituted indoles and uses thereof'20006,093,727'Imidazole and imidazoline derivatives and uses thereof'20006,046,331'Imidazolones and their use in treating benign prostatic hyperplasia and other disorders'20006,040,451'Substituted indoles and uses thereof'20006,015,819'Use of alpha-1C specific compounds to treat benign prostatic hyperplasia'20005,990,128'.alpha..sub.1C specific compounds to treat benign prostatic hyperplasia'19995,948,804'Substituted indoles and uses thereof'19995,942,517'5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines'19995,866,579'Imidazole and imidazoline derivatives and uses thereof'19995,863,948'Increasing aqueous humor outflow'19995,780,485'Use of .alpha..sub.1c specific compounds to treat benign prostatic hyperplasia'19985,767,131'Dihydropyridines and new uses thereof'19985,677,321'5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands'19975,610,174'Use of .alpha..sub.1A -selective adrenoceptor agonists for the treatment of urinary incontinence'19975,578,611'Use of .alpha.-1C specific compounds to treat benign prostatic hyperplasia'19965,574,066'Intraocular pressure reducing 15-acyl prostaglandins'19965,508,306'Aromatic amine derivatives'19965,453,509'Functionalization of acyl pyridinium salts'19955,418,234'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives'19955,403,847'Use of .alpha..sub.1C specific compounds to treat benign prostatic hyperlasia'19955,373,010'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives'19945,326,763'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives'19945,300,504'(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same'19945,252,595'Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines'19935,237,072'Method for producing amino-2-imidazoline derivatives'19935,231,096'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives'19935,204,347'Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines'19935,198,442'(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same'19935,151,440'Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines'19925,130,441'Method for producing amino-2-imidazoline derivatives'19925,112,822'(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same'19925,091,528'6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as .alpha. adrenergic agents'19925,077,292'(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same'19915,066,664'2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents'19915,034,413'Intraocular pressure reducing 9,11-diacyl prostaglandins'19915,034,406'Method for reducing or maintaining intraocular pressure'19915,021,416'Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure'19914,927,846'Intraocular pressure reducing 1,11-lactone prostaglandins'19904,725,620'2H-pyran-2,6-(3H)-dione derivatives with anti-allergic activity'1988

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1988–1996Patents assigned to ALLERGAN INC (21)· patent assignee history
1988–1999Based in Mission Viejo, CA, US· patent location history
1991Based in Mission Viego, CA, US· patent location history
1993–1995Based in Pompton Lakes, NJ, US· patent location history
1995–2004Patents assigned to SYNAPTIC PHARMA CORP (46)· patent assignee history
1995–2004Based in Wayne, NJ, US· patent location history
1999Patents assigned to MASSACHUSETTS EYE & EAR INFIRM (1)· patent assignee history
1999–2007Based in Danville, CA, US· patent location history
2007Patents assigned to MANIV ENERGY CAPITAL (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SYNAPTIC PHARMA CORP461995–2004
ALLERGAN INC211988–1996
MANIV ENERGY CAPITAL12007
MASSACHUSETTS EYE & EAR INFIRM11999
Locations
LocationPatentsSpan
Wayne, New Jersey, US261995–2004
Danville, California, US221999–2007
Mission Viejo, California, US161988–1999
Pompton Lakes, New Jersey, US41993–1995
Mission Viego, California, US11991